Home › Squamous Cell Carcinoma › Massachusetts › Boston

Pag-aaral pangklinika para sa Squamous Cell Carcinoma sa Boston, MA

Isang pag-aaral para sa Squamous Cell Carcinoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Boston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Nagre-recruitPhase 3

Boston Medical Center, Boston

Edad 60 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04892173

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Nagre-recruitPhase 1/2

Tufts Medical Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06561685

Toripalimab With Chemotherapy for Sinus Cancer

Nagre-recruitPhase 2

Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT06940180

PDT For Induction Therapy For Head And Neck Cancer

Nagre-recruitPhase 2

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07214987

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Nagre-recruitPhase 3

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 9, 2026 · NCT06064877

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2025 · NCT04370587

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Nagre-recruitPhase 1

Dana Farber/Partners Cancer Care Inc, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 15, 2025 · NCT04429542

Pag-aaral para sa Squamous Cell Carcinoma sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.